Clinical trial
Real-World Comparative Effectiveness and Safety of Anticoagulation, Thrombolysis, and Mechanical Thrombectomy in Intermediate-Risk Acute Pulmonary Embolism: A Multicenter Prospective Cohort Study
NCT07603700 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Comparative Effectiveness and Safety of Anticoagulation, Thrombolysis, and Mechanical Thrombectomy in Intermediate-Risk Acute Pulmonary Embolism: A Multicenter Prospective Cohort Study
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2029
- Enrollment
- 1,300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.